INO Financial Facts

Research and development: 16.69M
Net loss/ (gain) attributable to non-controlling interest: -85.86K
See Full Income Statement

Short-term investments - certificates of deposit: 84.3M
Common stock: 71.81K
See Full Balance Sheet

Inovio Pharma (INO) Earnings

  |   Expand Research on INO
Next EPS Date 11/10/15 *Est. EPS Growth Rate +50.0% *Last Qtr.
Average EPS % Beat Rate -7.4% Revenue Growth Rate +39.5% *Last Qtr.
Average % Move 1-Wk after EPS +10.1% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
8/10/15 Q215 -$0.09-$0.13 +$0.04$5.3M$5.52M N/A Details
5/11/15 Q115 -$0.17-$0.11 -$0.06$5.2M$7.04M N/A Details
3/16/15 Q414 -$0.12-$0.10 -$0.02$2.5M$5.24M N/A Details
11/10/14 Q314 -$0.12-$0.14 +$0.02$1.8M$5.6M N/A Details
8/11/14 Q214 -$0.18-$0.19 +$0.01$3.8M$1.8M N/A Details
5/12/14 Q114 -$0.05-$0.04 -$0.01$2.4M$1.41M N/A Details
3/17/14 Q413 -$0.04-$0.03 -$0.01$1.7M$1.36M N/A Details
11/12/13 Q313 $0.00-$0.02 +$0.02$9.5M$2.99M N/A Details